Anti-F4/80 antibody [BM8]
| Name | Anti-F4/80 antibody [BM8] |
|---|---|
| Supplier | Abcam |
| Catalog | ab16911 |
| Prices | $391.00 |
| Sizes | 100 µg |
| Host | Rat |
| Clonality | Monoclonal |
| Isotype | IgG2a |
| Clone | BM8 |
| Applications | ICC/IF ICC/IF IHC-P FC WB IHC-F |
| Species Reactivities | Mouse |
| Antigen | BALB/c macrophages obtained from 14-day-old bone marrow cell cultures |
| Description | Rat Monoclonal |
| Gene | Adgre1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab16911 staining mouse spleen tissue sections by immunohistochemistry (frozen sections). Sections were paraformaldehyde fixed without permeabilization and blocked in 1% serum for 10 minutes at 20°C. The primary antibody was used undiluted and incubated with sample for 16 hour at 20°C. A Biotin conjugated goat polyclonal to rat Ig, diluted 1/500 was used as the secondary antibody.See Abreview
ab16911 staining F4/80 in Mouse brain cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with acetone and blocked with 5% BSA for 1 hour at 20°C. Samples were incubated with primary antibody (1/250) for 16 hours at 4°C. An Alexa Fluor®568-conjugated Goat anti-rat IgG polyclonal (1/1000) was used as the secondary antibody.See Abreview
![Overlay histogram showing HeLa cells stained with ab16911 (red line). The cells were fixed with methanol (5 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab16911, 1/10 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rat IgG (Fc) (ab96971) at 1/250 dilution for 30 min at 22°C. Isotype control antibody (black line) was rat IgG2a [aRTK2758] (ab18450, 2µg/1x106 cells cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a significantly decreased signal in HeLa cells fixed with 4% paraformaldehyde (10 min) used under the same conditions.Please note that Abcam does not have data for use of this antibody on non-fixed cells. We welcome any customer feedback.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_2/16324_F480-Primary-antibodies-ab16911-7.jpg)
Overlay histogram showing HeLa cells stained with ab16911 (red line). The cells were fixed with methanol (5 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab16911, 1/10 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rat IgG (Fc) (ab96971) at 1/250 dilution for 30 min at 22°C. Isotype control antibody (black line) was rat IgG2a [aRTK2758] (ab18450, 2µg/1x106 cells cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a significantly decreased signal in HeLa cells fixed with 4% paraformaldehyde (10 min) used under the same conditions.Please note that Abcam does not have data for use of this antibody on non-fixed cells. We welcome any customer feedback.
ab16911 staining F4/80 on macrophages in mouse liver tissue by Immunohistochemistry (Frozen sections).
Product References
Effects of pregnancy on obesity-induced inflammation in a mouse model of fetal - Effects of pregnancy on obesity-induced inflammation in a mouse model of fetal
Ingvorsen C, Thysen AH, Fernandez-Twinn D, Nordby P, Nielsen KF, Ozanne SE, Brix S, Hellgren LI. Int J Obes (Lond). 2014 Oct;38(10):1282-9.
Neutrophil histone modification by peptidylarginine deiminase 4 is critical for - Neutrophil histone modification by peptidylarginine deiminase 4 is critical for
Martinod K, Demers M, Fuchs TA, Wong SL, Brill A, Gallant M, Hu J, Wang Y, Wagner DD. Proc Natl Acad Sci U S A. 2013 May 21;110(21):8674-9. doi:
Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue - Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue
Gauvreau D, Gupta A, Fisette A, Tom FQ, Cianflone K. PLoS One. 2013 Apr 22;8(4):e60795.
The transcription factor E26 transformation-specific sequence-1 mediates - The transcription factor E26 transformation-specific sequence-1 mediates
Feng W, Chumley P, Allon M, George J, Scott DW, Patel RP, Litovsky S, Jaimes EA. J Am Soc Nephrol. 2014 Mar;25(3):475-87.
A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO): - A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO):
Meyer zu Horste M, Stroher E, Berchner-Pfannschmidt U, Schmitz-Spanke S, Pink M, Gothert JR, Fischer JW, Gulbins E, Eckstein AK. J Clin Endocrinol Metab. 2011 Nov;96(11):E1727-36.
Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 - Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8
Pedretti M, Rancic Z, Soltermann A, Herzog BA, Schliemann C, Lachat M, Neri D, Kaufmann PA. Atherosclerosis. 2010 Feb;208(2):382-9. doi:
The endothelin receptor antagonist avosentan ameliorates nephropathy and - The endothelin receptor antagonist avosentan ameliorates nephropathy and
Watson AM, Li J, Schumacher C, de Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KA. Diabetologia. 2010 Jan;53(1):192-203.
Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium - Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium
Peng XD, Wu XH, Chen LJ, Wang ZL, Hu XH, Song LF, He CM, Luo YF, Chen ZZ, Jin K, Lin HG, Li XL, Wang YS, Wei YQ. J Pharmacol Exp Ther. 2010 Jan;332(1):46-56.
Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic - Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic
Jungraithmayr W, De Meester I, Matheeussen V, Inci I, Augustyns K, Scharpe S, Weder W, Korom S. Peptides. 2010 Apr;31(4):585-91.
Connective tissue growth factor promotes articular damage by increased - Connective tissue growth factor promotes articular damage by increased
Nozawa K, Fujishiro M, Kawasaki M, Kaneko H, Iwabuchi K, Yanagida M, Suzuki F, Miyazawa K, Takasaki Y, Ogawa H, Takamori K, Sekigawa I. Arthritis Res Ther. 2009;11(6):R174.